These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30969201)

  • 1. Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Lukes AS; Soper D; Harrington A; Sniukiene V; Mo Y; Gillard P; Shulman L
    Obstet Gynecol; 2019 May; 133(5):869-878. PubMed ID: 30969201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Liu JH; Soper D; Lukes A; Gee P; Kimble T; Kroll R; Mallick M; Chan A; Gillard P; Harrington A; Sniukiene V; Shulman LP
    Obstet Gynecol; 2018 Nov; 132(5):1241-1251. PubMed ID: 30303900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
    Simon JA; Catherino W; Segars JH; Blakesley RE; Chan A; Sniukiene V; Al-Hendy A
    Obstet Gynecol; 2018 Mar; 131(3):431-439. PubMed ID: 29420395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids.
    Donnez J; Hudecek R; Donnez O; Matule D; Arhendt HJ; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Terrill P; Osterloh I; Loumaye E
    Fertil Steril; 2015 Feb; 103(2):519-27.e3. PubMed ID: 25542821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term medical management of uterine fibroids with ulipristal acetate.
    Donnez J; Donnez O; Matule D; Ahrendt HJ; Hudecek R; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Loumaye E
    Fertil Steril; 2016 Jan; 105(1):165-173.e4. PubMed ID: 26477496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL).
    Coyne KS; Harrington A; Currie BM; Chen J; Gillard P; Spies JB
    J Patient Rep Outcomes; 2019 Aug; 3(1):57. PubMed ID: 31444600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
    Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
    Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ethnicity in treating uterine fibroids with ulipristal acetate.
    Murji A; Crosier R; Chow T; Ye XY; Shirreff L
    Fertil Steril; 2016 Oct; 106(5):1165-1169. PubMed ID: 27336213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study.
    Nieman LK; Blocker W; Nansel T; Mahoney S; Reynolds J; Blithe D; Wesley R; Armstrong A
    Fertil Steril; 2011 Feb; 95(2):767-72.e1-2. PubMed ID: 21055739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.
    Biscione A; Barra V; Bellone E; Severi FM; Luisi S
    Gynecol Endocrinol; 2020 Jan; 36(1):87-92. PubMed ID: 31328597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
    Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulipristal acetate: in uterine fibroids.
    Croxtall JD
    Drugs; 2012 May; 72(8):1075-85. PubMed ID: 22568731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.
    Cox J; Malik M; Britten J; Lewis T; Catherino WH
    Reprod Sci; 2018 Feb; 25(2):198-206. PubMed ID: 28929861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial.
    Levens ED; Potlog-Nahari C; Armstrong AY; Wesley R; Premkumar A; Blithe DL; Blocker W; Nieman LK
    Obstet Gynecol; 2008 May; 111(5):1129-36. PubMed ID: 18448745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.